Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

Europe - EBR:TESB - BE0003555639 - Common Stock

25.9 EUR
-0.9 (-3.36%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TESB. TESB was compared to 66 industry peers in the Chemicals industry. The financial health of TESB is average, but there are quite some concerns on its profitability. TESB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year TESB has reported negative net income.
In the past year TESB had a positive cash flow from operations.
Each year in the past 5 years TESB has been profitable.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

TESB has a worse Return On Assets (-0.96%) than 65.15% of its industry peers.
TESB has a worse Return On Equity (-1.52%) than 63.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.47%, TESB is in line with its industry, outperforming 43.94% of the companies in the same industry.
TESB had an Average Return On Invested Capital over the past 3 years of 6.25%. This is in line with the industry average of 7.12%.
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROIC 2.47%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TESB's Profit Margin has declined in the last couple of years.
TESB has a Operating Margin of 2.61%. This is comparable to the rest of the industry: TESB outperforms 45.45% of its industry peers.
In the last couple of years the Operating Margin of TESB has declined.
TESB has a Gross Margin of 19.33%. This is in the lower half of the industry: TESB underperforms 71.21% of its industry peers.
TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.61%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
TESB has less shares outstanding than it did 1 year ago.
TESB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TESB is higher compared to a year ago.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TESB has an Altman-Z score of 2.10. This is not the best score and indicates that TESB is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of TESB (2.10) is comparable to the rest of the industry.
The Debt to FCF ratio of TESB is 2.34, which is a good value as it means it would take TESB, 2.34 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of TESB (2.34) is better than 92.42% of its industry peers.
TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
TESB's Debt to Equity ratio of 0.06 is amongst the best of the industry. TESB outperforms 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Altman-Z 2.1
ROIC/WACC0.34
WACC7.19%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

TESB has a Current Ratio of 1.94. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.94, TESB is doing good in the industry, outperforming 62.12% of the companies in the same industry.
TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, TESB perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for TESB have decreased strongly by -131.08% in the last year.
TESB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.75% yearly.
The Revenue has been growing slightly by 2.05% in the past year.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%

3.2 Future

TESB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.97% yearly.
The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TESB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.72, which indicates a correct valuation of TESB.
TESB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TESB is cheaper than 65.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.35. TESB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.72
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

87.88% of the companies in the same industry are more expensive than TESB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, TESB is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.16
EV/EBITDA 5.3
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

TESB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TESB's earnings are expected to grow with 19.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.83%
EPS Next 3Y19.97%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
TESB's Dividend Yield is comparable with the industry average which is at 3.21.
TESB's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

On average, the dividend of TESB grows each year by 6.16%, which is quite nice.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

TESB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-166.05%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

TESSENDERLO GROUP

EBR:TESB (11/5/2025, 7:00:00 PM)

25.9

-0.9 (-3.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-21 2025-08-21
Earnings (Next)03-24 2026-03-24/amc
Inst Owners6.25%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.56B
Revenue(TTM)2.75B
Net Income(TTM)-27100000
Analysts74
Price Target27.8 (7.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.72
P/S 0.57
P/FCF 14.16
P/OCF 5.4
P/B 0.87
P/tB 1
EV/EBITDA 5.3
EPS(TTM)-0.45
EYN/A
EPS(NY)1.76
Fwd EY6.79%
FCF(TTM)1.83
FCFY7.06%
OCF(TTM)4.8
OCFY18.52%
SpS45.64
BVpS29.62
TBVpS25.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROCE 3.29%
ROIC 2.47%
ROICexc 2.77%
ROICexgc 3.14%
OM 2.61%
PM (TTM) N/A
GM 19.33%
FCFM 4.01%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexgc growth 3Y-43.17%
ROICexgc growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Debt/EBITDA 0.38
Cap/Depr 80.05%
Cap/Sales 6.5%
Interest Coverage 7.18
Cash Conversion 97.86%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 2.1
F-Score6
WACC7.19%
ROIC/WACC0.34
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year250.49%
EBIT Next 3Y60.07%
EBIT Next 5YN/A
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.17%
OCF growth 3Y10.33%
OCF growth 5Y8.69%

TESSENDERLO GROUP / TESB.BR FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


What is the valuation status of TESSENDERLO GROUP (TESB.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for TESSENDERLO GROUP?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for TESB stock?

The financial health rating of TESSENDERLO GROUP (TESB.BR) is 6 / 10.